Lv41
428 积分 2020-06-18 加入
FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
33分钟前
待确认
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
2小时前
已完结
RareCyte® CTC Analysis Step 1: AccuCyte® Sample Preparation for the Comprehensive Recovery of Nucleated Cells from Whole Blood
2个月前
已完结
Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer
2个月前
已完结
Lactate programs PBX1 lactylation and mesangial proliferation in lupus nephritis
6个月前
已完结
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing
6个月前
已完结
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing
6个月前
已完结
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack
7个月前
已完结
Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis
8个月前
已完结
Macrophages harness hepatocyte glutamate to boost liver regeneration
8个月前
已完结
皖公网安备34019202002308
